• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中一元胺、谷氨酸和γ-氨基丁酸之间的相互作用:新证据

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.

作者信息

Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson M L

机构信息

Institute of Physiology and Pharmacology, University of Göteborg, Göteborg, Sweden.

出版信息

Annu Rev Pharmacol Toxicol. 2001;41:237-60. doi: 10.1146/annurev.pharmtox.41.1.237.

DOI:10.1146/annurev.pharmtox.41.1.237
PMID:11264457
Abstract

In spite of its proven heuristic value, the dopamine hypothesis of schizophrenia is now yielding to a multifactorial view, in which the other monoamines as well as glutamate and GABA are included, with a focus on neurotransmitter interactions in complex neurocircuits. The primary lesion(s) in schizophrenia does not necessarily involve any of these neurotransmitters directly but could deal with a more general defect, such as a faulty connectivity of developmental origin. Nevertheless, a precise identification of neurotransmitter aberrations in schizophrenia will probably provide clues for a better understanding of the disease and for the development of new treatment and prevention strategies.

摘要

尽管精神分裂症的多巴胺假说已被证明具有启发价值,但现在它正让位于一种多因素观点,该观点纳入了其他单胺类物质以及谷氨酸和γ-氨基丁酸,并侧重于复杂神经回路中的神经递质相互作用。精神分裂症的原发性病变不一定直接涉及这些神经递质中的任何一种,而可能与更普遍的缺陷有关,例如发育起源的连接错误。然而,精确识别精神分裂症中的神经递质异常可能会为更好地理解该疾病以及开发新的治疗和预防策略提供线索。

相似文献

1
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.精神分裂症中一元胺、谷氨酸和γ-氨基丁酸之间的相互作用:新证据
Annu Rev Pharmacol Toxicol. 2001;41:237-60. doi: 10.1146/annurev.pharmtox.41.1.237.
2
Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia.α7 型烟碱型乙酰胆碱能神经调质可能调和精神分裂症的多种神经递质假说。
Med Hypotheses. 2012 May;78(5):594-600. doi: 10.1016/j.mehy.2012.01.035. Epub 2012 Feb 13.
3
Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?精神分裂症的神经回路模型:是多巴胺、γ-氨基丁酸、谷氨酸,还是其他因素?
Biol Psychiatry. 2009 Jun 15;65(12):1003-5. doi: 10.1016/j.biopsych.2009.04.006.
4
[A biochemical theory of schizophrenia].[精神分裂症的一种生化理论]
Nervenarzt. 1984 Nov;55(11):602-6.
5
Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity.谷氨酸、γ-氨基丁酸和多巴胺系统与烟酰胺腺嘌呤二核苷酸还原型诱导的神经毒性的关系研究进展
Biol Psychiatry. 1995 Dec 15;38(12):783-7. doi: 10.1016/0006-3223(95)00529-3.
6
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.抗精神病药物的作用机制:从多巴胺D(2)受体拮抗到谷氨酸N-甲基-D-天冬氨酸受体易化
Clin Ther. 2005;27 Suppl A:S16-24. doi: 10.1016/j.clinthera.2005.07.017.
7
The biological basis of schizophrenia: new directions.精神分裂症的生物学基础:新方向
J Clin Psychiatry. 1997;58 Suppl 10:22-7.
8
The interaction between GABA and dopamine: implications for schizophrenia.γ-氨基丁酸(GABA)与多巴胺之间的相互作用:对精神分裂症的影响。
Schizophr Bull. 1983;9(3):336-53. doi: 10.1093/schbul/9.3.336.
9
Pathophysiologically based treatment interventions in schizophrenia.基于病理生理学的精神分裂症治疗干预措施。
Nat Med. 2006 Sep;12(9):1016-22. doi: 10.1038/nm1478.
10
[Dopaminergic receptor activity and the evolution of schizophrenia].[多巴胺能受体活性与精神分裂症的演变]
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1985 Apr-Jun;30(2):131-4.

引用本文的文献

1
Large-scale maps of altered cortical dynamics in early-stage psychosis are related to GABAergic and glutamatergic neurotransmission.早期精神病中皮质动力学改变的大规模图谱与γ-氨基丁酸能和谷氨酸能神经传递有关。
Sci Adv. 2025 Aug 15;11(33):eads0400. doi: 10.1126/sciadv.ads0400. Epub 2025 Aug 13.
2
Amphetamine Injection into the Nucleus Accumbens and Electrical Stimulation of the Ventral Tegmental Area in Rats After Novelty Test-Behavioral and Neurochemical Correlates.新奇性测试后大鼠伏隔核注射苯丙胺及腹侧被盖区电刺激——行为学与神经化学相关性
Int J Mol Sci. 2024 Dec 28;26(1):182. doi: 10.3390/ijms26010182.
3
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults.
中枢神经系统药物:老年人的药代动力学和药效学考虑。
Drugs Aging. 2024 Jun;41(6):507-519. doi: 10.1007/s40266-024-01117-w. Epub 2024 May 30.
4
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders.释放乌洛托品作为痕量胺相关受体1激动剂对神经精神疾病的治疗潜力。
Biomedicines. 2023 Jul 13;11(7):1977. doi: 10.3390/biomedicines11071977.
5
Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function.首发精神分裂症、双相情感障碍、重度抑郁症患者血浆神经肽水平降低:与临床症状及认知功能的关联
Front Psychiatry. 2023 May 19;14:1180720. doi: 10.3389/fpsyt.2023.1180720. eCollection 2023.
6
Lipopolysaccharide Exacerbates Ketamine-Induced Psychotic-Like Behavior, Oxidative Stress, and Neuroinflammation in Mice: Ameliorative Effect of Diosmin.脂多糖加剧氯胺酮诱导的小鼠类精神病行为、氧化应激和神经炎症:地奥司明的改善作用
J Mol Neurosci. 2023 Mar;73(2-3):129-142. doi: 10.1007/s12031-022-02077-9. Epub 2023 Jan 18.
7
The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review.去甲肾上腺素能和胆碱能系统的神经调节作用及其在认知功能中的相互作用:一篇重点综述。
Brain Sci. 2022 Jul 7;12(7):890. doi: 10.3390/brainsci12070890.
8
Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders.应用快速扫描循环伏安法探索神经精神疾病动物模型中的多巴胺动态。
Cells. 2022 May 3;11(9):1533. doi: 10.3390/cells11091533.
9
Schizophrenia, Bipolar Disorder and Pre-Attentional Inhibitory Deficits.精神分裂症、双相情感障碍与前注意抑制缺陷
Neuropsychiatr Dis Treat. 2022 Apr 8;18:821-827. doi: 10.2147/NDT.S352157. eCollection 2022.
10
Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics.超越抗精神病药:二十一世纪精神分裂症治疗药物的临床前开发更新。
Transl Psychiatry. 2022 Apr 7;12(1):147. doi: 10.1038/s41398-022-01904-2.